Josh Arnold Investment Consultant LLC Invests $604,000 in Clarivate Plc (NYSE:CLVT)

Josh Arnold Investment Consultant LLC purchased a new stake in Clarivate Plc (NYSE:CLVT) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 85,000 shares of the company’s stock, valued at approximately $604,000. Clarivate makes up 0.5% of Josh Arnold Investment Consultant LLC’s investment portfolio, making the stock its 17th biggest holding.

A number of other large investors also recently bought and sold shares of CLVT. Price T Rowe Associates Inc. MD grew its stake in Clarivate by 5.6% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 247,446 shares of the company’s stock worth $1,839,000 after buying an additional 13,103 shares during the last quarter. Boston Partners raised its position in Clarivate by 76.3% during the first quarter. Boston Partners now owns 557,496 shares of the company’s stock valued at $4,140,000 after acquiring an additional 241,292 shares in the last quarter. Transcend Capital Advisors LLC purchased a new position in shares of Clarivate during the 2nd quarter valued at approximately $86,000. SG Americas Securities LLC purchased a new position in Clarivate in the second quarter valued at $1,410,000. Finally, Wealth Enhancement Advisory Services LLC boosted its stake in shares of Clarivate by 19.2% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 52,229 shares of the company’s stock worth $297,000 after acquiring an additional 8,430 shares in the last quarter. Institutional investors own 85.72% of the company’s stock.

Insider Activity

In other Clarivate news, insider Bar Veinstein sold 60,000 shares of the business’s stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $7.00, for a total value of $420,000.00. Following the transaction, the insider now directly owns 916,583 shares of the company’s stock, valued at approximately $6,416,081. The trade was a 6.14 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Michael J. Angelakis acquired 1,500,000 shares of the business’s stock in a transaction on Wednesday, November 20th. The shares were purchased at an average price of $5.11 per share, with a total value of $7,665,000.00. Following the transaction, the director now owns 1,500,000 shares in the company, valued at $7,665,000. The trade was a ∞ increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 22.77% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the company. Barclays decreased their target price on Clarivate from $5.00 to $4.00 and set an “underweight” rating on the stock in a research report on Thursday, November 7th. William Blair cut shares of Clarivate from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 6th. Finally, Royal Bank of Canada reduced their price objective on Clarivate from $7.00 to $6.00 and set a “sector perform” rating on the stock in a research report on Thursday, November 7th. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $7.25.

Clarivate Trading Down 0.5 %

CLVT stock opened at $5.73 on Friday. The business’s 50-day moving average is $6.08 and its two-hundred day moving average is $6.10. Clarivate Plc has a 1 year low of $4.25 and a 1 year high of $9.60. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.84.

Clarivate (NYSE:CLVT) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.19 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.19. Clarivate had a positive return on equity of 9.69% and a negative net margin of 50.00%. The company had revenue of $622.20 million during the quarter, compared to the consensus estimate of $640.81 million. During the same period in the previous year, the business earned $0.18 EPS. Clarivate’s revenue for the quarter was down 3.9% on a year-over-year basis. On average, equities research analysts anticipate that Clarivate Plc will post 0.63 EPS for the current fiscal year.

Clarivate Company Profile

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.